Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04654182 · ClinicalTrials.gov registry record · Phase 4
Evaluation of the Residual Antimicrobial Efficacy of One Test Material Based on a Modification of ASTM E1115-11 Test Method
A Phase 4 study, sponsored by Molnlycke Health Care AB.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT04654182 is a Phase 4 study that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 32 participants.
The verdict
NCT04654182, a Phase 4 study, has completed, sponsored by Molnlycke Health Care AB.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
To evaluate the residual antimicrobial effectiveness of one test product when tested using a modification of the methodology of the standardized ASTM E115-11 (2017)
Interventions
- DRUG Chlorhexidine Gluconate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-11-30 |
| Est. Completion | 2020-12-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04654182
The ClinicalTrials.gov registry entry for NCT04654182 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chlorhexidine Gluconate is the first listed.
NCT04654182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04654182 about?
NCT04654182 is a clinical study titled "Evaluation of the Residual Antimicrobial Efficacy of One Test Material Based on a Modification of ASTM E1115-11 Test Method". To evaluate the residual antimicrobial effectiveness of one test product when tested using a modification of the methodology of the standardized ASTM E115-11 (2017)
What is the current status of trial NCT04654182?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2020-11-30. Estimated completion is 2020-12-24.
What interventions are being tested in trial NCT04654182?
The interventions under investigation include: Chlorhexidine Gluconate (DRUG).
Who is sponsoring clinical trial NCT04654182?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.